While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...

Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...

In September 2024, the European Commission (EC) granted marketing authorization for an updated formulation of Moderna's COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1, for ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was ...

Inc. MRNA was awarded a tender to supply its mRNA COVID-19 vaccine in the European Union (EU). What Happened: Seventeen participating countries—including Norway and North Macedonia—can access ...